Lung Cancer Trials Ask AI to find trials
RecruitingNot applicableNCT01885299
Official study title

RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT

Study summary

The RSSearch® Registry is an international multi-year database designed to track SRS/SBRT (Stereotactic Radiosurgery/Stereotactic Body Radiation Therapy) utilization, treatment practices and outcomes to help determine, over time, the most effective use of these systems in management of patients with life threatening tumors and other diseases. (This study was formally called ReCKord and included the CyberKnife only; The ReCKord study continues as a CyberKnife subset of RSSearch.)

Ask AI to explain this study
Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedSRS/SBRT

The study team can explain what participation involves.

Who it may be forNeoplasms · Arteriovenous Malformation of Central Nervous System

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Sep 19, 2024 · Source: ClinicalTrials.gov

Is enrollment open?Recruiting

The study is currently accepting participants.

What kind of study?Not applicable

Observational

Where is it offered?13 U.S. locations

Locations may change over time.

Who runs it?The Radiosurgery Society

Study sponsor

01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
The Radiosurgery Society
Interventions being studied
Radiation: SRS/SBRT
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach
Radiation therapy→Surgery→
03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • Diagnosis of benign or malignant tumors or other conditions deemed treatable by stereotactic radiosurgery or stereotactic body radiotherapy
  • Willingness to sign an Informed Consent Document or verbally agree to participation
Reasons someone may not be able to joinExclusion criteria

There are no specific

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Penrose Cancer CenterColorado Springs, Colorado
  • Sylvester Comprehensive Cancer Center, University of MiamiMiami, Florida
  • Southeast Georgia Health SystemBrunswick, Georgia
  • Henry Ford Health SystemDetroit, Michigan
  • AtlantiCare Regional Medical Center and AtlantiCare Cancer Care InstituteEgg Harbor, New Jersey
  • Riverview Medical CenterRed Bank, New Jersey
  • NJ Cyberknife at Community Medical CenterToms River, New Jersey
  • Montefiore Medical CenterThe Bronx, New York
  • Geisinger Health SystemDanville, Pennsylvania
  • Philadelphia CyberKnifePhiladelphia, Pennsylvania
  • Pottstown Memorial Medical CenterPottstown, Pennsylvania
  • Cyberknife at ErlangerChattanooga, Tennessee

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Sep 19, 2024. Always confirm current availability with the study team.

View original record ↗